Nature Reviews Gastroenterology and Hepatology
| 短名 | Nat Rev Gastroenterol Hepatol |
| Journal Impact | 45.80 |
| 国际分区 | GASTROENTEROLOGY & HEPATOLOGY(Q1) |
| 期刊索引 | SCI Q1中科院 1 区 |
| ISSN | 1759-5045, 1759-5053 |
| h-index | 193 |
| 国内分区 | 医学(1区)医学胃肠肝病学(1区) |
| Top期刊 | 是 |
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY 的基础、转化和临床内容由国际知名的基础和临床学者和研究人员撰写，面向研究生以上生物和医学科学的读者。虽然旨在由专业内的执业医生、研究人员和学者阅读，但我们的目标是让任何生物学或医学学科的读者都能访问我们的所有文章。深入评论提供有关某个主题的权威、最新信息, 将其置于一个领域的历史和发展的背景下。共识声明提供了基于证据或基于卓越的建议，并提出了由专家工作组汇总的平衡审查。在 PERSPECTIVES, COMMENTS 中提供了专题讨论和意见和新闻与观点文章，在“研究亮点”部分，我们从一系列专业和普通医学和科学期刊中筛选出主要研究。涵盖的主题：-癌症-诊断和筛查-内窥镜检查（包括成像）-流行病学-胆囊和胆道道-胃食管反流病-胃肠道出血-遗传学-老年医学-肠道菌群-肝炎-感染（包括细菌、病毒、寄生虫抽动）-炎症性肠病-大肠（包括肛门）-肝脏（包括肝硬化和纤维化）-运动（包括肠易激综合征）-营养（包括消化、不耐受、过敏、治疗、肥胖）-胰腺-儿科-小肠-胃-手术（包括移植）-治疗（包括药物治疗、放射治疗、营养、替代）-转化医学-溃疡-上消化道（包括口腔、食道、摄入）
期刊主页投稿网址| 涉及主题 | 医学生物内科学化学生物化学遗传学病理胃肠病学重症监护医学免疫学政治学法学外科疾病梅德林内分泌学 |
| 出版信息 | 出版商: Nature Research，出版周期: Monthly，期刊类型: journal |
| 基本数据 | 创刊年份: 2009，原创研究文献占比: 28.07%，自引率:0.70%， Gold OA占比: 4.32% |
| 平均审稿周期 | 网友分享经验：较慢,6-12周 |
| 平均录用比例 | 网友分享经验：很难 |
期刊引文格式
这些示例是对学术期刊文章的引用，以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章，因此这些字段是可选的。有些电子期刊不提供页面范围，而是列出文章标识符。在这种情况下，使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用，以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
A greener gastroenterology: challenges and opportunities for an eco-sustainable approach to digestive diseases
2024-9-12
Ammonia-induced stress response in liver disease progression and hepatic encephalopathy
2024-9-9
Characterizing the genomic landscape of colorectal cancer
2024-9-9
AI-based tool for scoring MASH histology
2024-9-6
GLP1 agonists: current and future landscape of clinical trials for patients with metabolic dysfunction
2024-9-6
Hepatic immune regulation and sex disparities
2024-9-5
Consequences of bathroom restriction on transgender individuals with gastrointestinal conditions in the United States
2024-9-2
Intestinal organ chips for disease modelling and personalized medicine
2024-8-27
Mapping neuroimmune interactions in the gut
2024-8-22
Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: burden, trends, challenges and future directions
2024-8-15
EPC 2024
2024-8-12
Cellular and molecular basis of proximal small intestine disorders
2024-8-8
Risankizumab versus ustekinumab for Crohn’s disease: a phase IIIb study
2024-8-5
EASL Congress 2024
2024-8-5
Metastatic pancreatic cancer and the liver
2024-8-5
Author Correction: A roadmap for clinical trials in MASH-related compensated cirrhosis
2024-8-5
Food inequity and insecurity and MASLD: burden, challenges, and interventions
2024-7-29
Mother-to-child transmission of hepatitis B: current status and the road forward
2024-7-28
Viral hepatitis elimination — time to act
2024-7-28
Western lifestyle, metaflammation and the cell of origin of colon cancer
2024-7-24
Hepatitis E virus: from innate sensing to adaptive immune responses
2024-7-22
Shifting targets for eosinophilic oesophagitis
2024-7-22
A roadmap for clinical trials in MASH-related compensated cirrhosis
2024-7-17
Disability inclusion in research and health care
2024-7-15
Fgfbp1+ cells: upper crypt intestinal epithelial regeneration
2024-7-11
Neoadjuvant immunotherapy for mismatch repair-deficient colon cancer: a phase II study
2024-7-11
A bloody disgrace — time to change patient safety culture
2024-7-8
Incretin-based therapies for liver disease
2024-7-8
ETS2 regulates human inflammatory macrophages in IBD
2024-7-2
Digestive Disease Week 2024
2024-6-17
Intermittent fasting for NASH and HCC in mice
2024-6-14
Unlocking the promise of RAS inhibition in pancreatic cancer
2024-6-14
Next generation of gastrointestinal electrophysiology devices
2024-6-14
Designing clinical trials to address alcohol use and alcohol-associated liver disease: an expert panel Consensus Statement
2024-6-7
Shaping new paths in clinical trial design to address alcohol use disorders and alcohol-associated liver disease
2024-6-7
Envisioning how to advance the MASH field
2024-6-4
A global consensus on the definitions, diagnosis and management of fibrostenosing small bowel Crohn’s disease in clinical practice
2024-6-3
Hybrid APASL meeting 2024
2024-6-3
Endogenous ethanol production in health and disease
2024-6-3
Pride in gastroenterology and hepatology
2024-5-31
Mechanisms of metastatic colorectal cancer
2024-5-28
Positive phase III trials for ileal bile acid transporter inhibitors
2024-5-23
Sex and ethnic disparities persist in hepatitis B management
2024-5-22
Microbiota and colorectal cancer — controlling for confounders challenges associations
2024-5-21
A single-cell multiomics profile of Fontan-associated liver disease
2024-5-21
Pleasurable and problematic receptive anal intercourse and diseases of the colon, rectum and anus
2024-5-19
Development of MKK4 inhibitors for liver regeneration
2024-5-15
Telemedicine for hepatitis C virus treatment in opioid treatment programmes
2024-5-15
Rhythmicity of infant microbiota and dietary effects
2024-5-14
Multi-omic links between gut microbiome and cardiovascular disease
2024-5-14
帮你贴心管理全部的文献
研飞ivySCI，高效的论文管理
投稿经验分享
分享我的经验，帮你走得更远